APDN Applied DNA Sciences Inc

Applied DNA Sciences, Inc. (OTCBB: APDN), a provider of DNA-based security, anti-counterfeiting technology and product authentication solutions, will host a conference call to update investors on Thursday, August 11, 2011.

Applied DNA Sciences, Inc. management will host a thirty-minute conference call beginning at 9:00 a.m. eastern daylight time on Thursday, August 11, 2011 to discuss the company's performance and outline key ongoing and future business initiatives. A presentation by CEO and President James Hayward will be followed by a question-and-answer session.

All participants must pre-register using the link below. It is suggested that you log into the conference call approximately 10 minutes prior to the scheduled start time to ensure that all participants are on-line at the start of the call. While callers cannot be heard during the call, questions may be emailed beforehand or texted during the session (see below for details). For those of you unable to participate, a transcript of the call will be posted by end of business on August 11, and available under the "Investors" tab of the company's web site.

To Participate: Reserve your spot now at: https://www3.gotomeeting.com/register/618171238

To Send Questions Prior to or During the Call: Please email questions prior to the call to investor@adnas.com. During the conference call, questions can be texted once you are registered as a participant.

Due to the large number of expected participants, not all questions may be answered on the call.

Company Background Materials: You may be interested in the company's Investor Information section on the company's web site, including Publications, Recent Press Releases, blogs, and other materials.

About APDN APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied, and provide a forensic chain of evidence that can be used to prosecute perpetrators. Its DNA marking systems have been certified and validated at government level, including in the EU. The company is located at 25 Health Sciences Drive, Suite 215, Stony Brook, NY 11790. For more information on APDN (OTCBB: APDN), visit www.adnas.com, on Twitter at @APDN.

The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 15, 2010 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

Add to Digg Bookmark with del.icio.us Add to Newsvine

INVESTOR CONTACT: Debbie Bailey 631-444-8090 MEDIA CONTACT: Janice Meraglia 631-444-6293 FCMN Contact: Email Contact Web site: http://www.adnas.com Twitter: @APDN